Case Study MSN

MSN aimed at achieving a paperless LIMS and complete audit- readiness while scaling up its laboratory operations. They wanted to automate their labs. With digitalization of processes, they aimed at functioning at their highest potential.

About MSN

MSN, founded in 2003, is a fast-growing pharmaceutical manufacturing company with headquarters in India, Myanmar, and the USA. It specializes in the production of life-saving drugs with 9 API facilities, 5 finished dosage facilities, and an integrated R&D center for formulation and API. They have bagged 836 patents to date and cater to more than 40 million patients globally. Their product portfolio features over 450+ APIs and 300+ formulations.

MSN is backed by its mission to improve quality of life by manufacturing safe, innovative, affordable pharmaceuticals. The company invests in innovative R&D facilities, robust IP strategy, and insight-driven IT to create innovative solutions for tomorrow’s healthcare requirements.

Paper-Related Process Inefficiencies Restricted Progress

Engaged in critical manufacturing, laboratories have complicated processes and stringent regulatory requirements. While cutting-edge science and state-of-the-art technology kept MSN abreast of technological innovations, some issues restricted operational efficiencies.

With a paper-based laboratory, MSN faced major challenges that limited its operations in today’s technology-driven industry. Paper- based entries and manual data management at the MSN labs led to process limitations and huge racks with piles of paper documents made it difficult to fetch accurate data when needed.